Today's TradingHard to read, over 600,000 shares traded on nasdaq, only 59,000 on TSX. A green number of .15 cents. Could also be another institutional seller, who has had enough watching this management team fumble the football.
Looks like the long term bet should be made with Greg Crawford over at Quipt, formerly Protech, spun out of PHM. Current run rate of around 105 million, predicting 135 million in 2022, 20% plus EBITA margins, 150,000 active patients, growing organically and by way of acquisition, specifically on the respitory side
Well worth a look, so tell me VMD board why the hell isn't Casey Hoyt doing this, instead of just sitting around talking about doing it. I just don't get it, what are these new hires doing at Viemed??